![]() |
|
|
Vol. 20, Issue 6, 1785-1794, March 15, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, L-Selectin, and Tumor Necrosis Factor 
,


*Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021;
Centre National de la Recherche Scientifique, Formation de Recherche en Evolution 2937, Laboratoire d'Oncologie virale, 94801 Villejuif, France;
Université Paris-Sud XI, 91405 Orsay, France;
Biochemical Institute, Christian-Albrechts-University, 24098 Kiel, Germany; ||Department of Anti-aging Orthopedic Research and Orthopedic Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan; ¶Department of Inflammation, Schering Plough Research Institute, Kenilworth, NJ 07033-0539; #Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298; and @Departments of Medicine, and of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021
Submitted November 20, 2008;
Revised January 2, 2009;
Accepted January 9, 2009
Monitoring Editor: Benjamin Margolis
Protein ectodomain shedding is a critical regulator of many membrane proteins, including epidermal growth factor receptor-ligands and tumor necrosis factor (TNF)-
, providing a strong incentive to define the responsible sheddases. Previous studies identified ADAM17 as principal sheddase for transforming growth factor (TGF)-
and heparin-binding epidermal growth factor, but Ca++ influx activated an additional sheddase for these epidermal growth factor receptor ligands in Adam17–/– cells. Here, we show that Ca++ influx and stimulation of the P2X7R signaling pathway activate ADAM10 as sheddase of many ADAM17 substrates in Adam17–/– fibroblasts and primary B cells. Importantly, although ADAM10 can shed all substrates of ADAM17 tested here in Adam17–/– cells, acute treatment of wild-type cells with a highly selective ADAM17 inhibitor (SP26) showed that ADAM17 is nevertheless the principal sheddase when both ADAMs 10 and 17 are present. However, chronic treatment of wild-type cells with SP26 promoted processing of ADAM17 substrates by ADAM10, thus generating conditions such as in Adam17–/– cells. These results have general implications for understanding the substrate selectivity of two major cellular sheddases, ADAMs 10 and 17.
Address correspondence to: Carl P. Blobel (blobelc{at}hss.edu)
This article has been cited by other articles:
![]() |
F. Schelter, J. Kobuch, M. L. Moss, J. D. Becherer, P. M. Comoglio, C. Boccaccio, and A. Kruger A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor J. Biol. Chem., August 20, 2010; 285(34): 26335 - 26340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mendelson, S. Swendeman, P. Saftig, and C. P. Blobel Stimulation of Platelet-derived Growth Factor Receptor {beta} (PDGFR{beta}) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFR{beta} and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways J. Biol. Chem., August 6, 2010; 285(32): 25024 - 25032. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Hassemer, S. M. Le Gall, R. Liegel, M. McNally, B. Chang, C. J. Zeiss, R. D. Dubielzig, K. Horiuchi, T. Kimura, Y. Okada, et al. The waved with open eyelids (woe) Locus Is a Hypomorphic Mouse Mutation in Adam17 Genetics, May 1, 2010; 185(1): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. C. Zhang, Z. Ni, A. Herrera, and B. Walcheck ADAM17 Activity and Other Mechanisms of Soluble L-selectin Production during Death Receptor-Induced Leukocyte Apoptosis J. Immunol., April 15, 2010; 184(8): 4447 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Jacobsen, L. Adlerz, G. Multhaup, and K. Iverfeldt Insulin-like Growth Factor-1 (IGF-1)-induced Processing of Amyloid-{beta} Precursor Protein (APP) and APP-like Protein 2 Is Mediated by Different Metalloproteinases J. Biol. Chem., April 2, 2010; 285(14): 10223 - 10231. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Strooper Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process Physiol Rev, April 1, 2010; 90(2): 465 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clemente, E. Sisman, P. Aza-Blanc, and J. C. de la Torre Identification of Host Factors Involved in Borna Disease Virus Cell Entry through a Small Interfering RNA Functional Genetic Screen J. Virol., April 1, 2010; 84(7): 3562 - 3575. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Weskamp, K. Mendelson, S. Swendeman, S. Le Gall, Y. Ma, S. Lyman, A. Hinoki, S. Eguchi, V. Guaiquil, K. Horiuchi, et al. Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes Circ. Res., March 19, 2010; 106(5): 932 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Gibb, M. El Shikh, D.-J. Kang, W. J. Rowe, R. El Sayed, J. Cichy, H. Yagita, J. G. Tew, P. J. Dempsey, H. C. Crawford, et al. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo J. Exp. Med., March 15, 2010; 207(3): 623 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Myers, L. H. Brennaman, M. Stevenson, S. Higashiyama, W. E. Russell, D. C. Lee, and S. W. Sunnarborg Mitochondrial Reactive Oxygen Species Mediate GPCR-induced TACE/ADAM17-dependent Transforming Growth Factor-{alpha} Shedding Mol. Biol. Cell, December 15, 2009; 20(24): 5236 - 5249. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Bozkulak and G. Weinmaster Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling Mol. Cell. Biol., November 1, 2009; 29(21): 5679 - 5695. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, C. Sharma, and M. E. Hemler Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein FASEB J, November 1, 2009; 23(11): 3674 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, L. Bruckner-Tuderman, and C. P. Blobel Shedding of Collagen XVII/BP180 in Skin Depends on Both ADAM10 and ADAM9 J. Biol. Chem., August 28, 2009; 284(35): 23386 - 23396. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme J. Immunol., June 15, 2009; 182(12): 7408 - 7414. [Abstract] [Full Text] [PDF] |
||||